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Introduction:
- Sedation is necessary in the Intensive Care Unit
(ICU) for patient comfort and the avoidance of
ventilator dyssynchrony and unplanned
extubation.

Discussion:
- Days #2-21: The patient is managed with
diuretics, milrinone, nesiritide and antibiotics
while demonstrating little clinical improvement.

- Opioid tolerant patients can be challenging to
sedate despite high doses of benzodiazepines and
opioids.

- Day #22: Extracorporeal Membrane Oxygenation
(ECMO) is started to compensate for the patient’s
decreased cardiac function in the Surgery
Coronary Care Unit (SCCU).

- Escalating opioid doses may actually exacerbate
opioid tolerance, induce hyperalgesia, and cause/
worsen cardiovascular and respiratory depression.1,7

- Day #32: The patient is switched to LVAD with
an open chest due to inadequate intraoperative
hemostasis.

- Ketamine may be useful as an adjunct in a
multimodal approach in order to maximize both
pain control and sedation in select patients who
require very high doses of opioids and
benzodiazepines.6

- Day #33: The acute pain service is consulted for
inadequate sedation and pain uncontrolled by
conventional means. At the time of consultation,
the patient is receiving 300mcg/hr of fentanyl and
18mg/hr of midazolam. RASS score is “-3
moderate sedation.”

Case Description:
- Day #1: A 5’10”, 110 kg 28 year old male with
no past medical history is admitted for workup of
progressive shortness of breath over 2 months and
worsening lower extremity edema over 2 weeks.
- Day #2: TEE shows pulmonary arterial pressure of
60/30, wedge pressure of 28, right atrial pressure
of 22, and cardiac output of 4.5. Nonischemic
cardiomyopathy is suspected.
-

- Days #35-48: The patient is brought to the OR
several times for washouts secondary to persistent
fever and several positive bacterial cultures. His
fentanyl largely hovers around the 50-100mcg/hr
range and his midazolam requirements are
consistently minimal (as low as 3mg/hr).
- Day #48: Ketamine is ultimately discontinued
after the patient develops septic shock and is consequently placed on a number of vasopressors.

- Ketamine may be a useful adjunct to other
sedatives for improving comfort in patients who
require analgesia and are already on high doses
of opioids and benzodiazepines.
- Opioid tolerance is of particular concern, as
benzodiazepines have been shown to accelerate
this process. This is postulated to be the result of
decreased activity in the descending inhibitory
nervous system.3
- A multimodal regimen with ketamine offers the
advantage of reducing opioid requirements as
well as the risk of opioid tolerance and
hyperalgesia. This may result from a reduction
in central hyperexcitability due to ketamine’s
activity at the N-methyl-D-aspartate (NMDA)
receptor. 2,6
- In our patient, we observed a dramatic decrease
in the amount of midazolam and fentanyl
required for sedation and analgesia following the
administration of ketamine.

- Day #33: Ketamine is started at 20mg/hr with
a 10mg bolus and subsequently titrated up to
60mg/hr over the next six hours.
- Days #33-34, 12 hours later: Fentanyl is tapered
down to 100mcg/hr and midazolam to 14mg/hr.
- Day # 34: Fentanyl is decreased to 50mcg/hr and
midazolam to 4mg/hr while the ketamine infusion
continues at 60mg/hr. RASS score is “-2 light
sedation.”

NMDA Receptor

Conclusion:
- A multimodal sedative and analgesic regimen that incorporates ketamine offers important therapeutic
advantages in select patients who
require very high doses of opioids
and benzodiazepines, but warrants
further study.
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